Cited 9 time in
Drug resistance in extra-pulmonary tuberculosis in South Korea: comparison with pulmonary tuberculosis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mok, J. | - |
| dc.contributor.author | Kang, B. H. | - |
| dc.contributor.author | Kim, H-J. | - |
| dc.contributor.author | Lee, S. J. | - |
| dc.contributor.author | Lee, T. | - |
| dc.contributor.author | Lee, H-K. | - |
| dc.contributor.author | Cho, Y. J. | - |
| dc.contributor.author | Jeon, D. | - |
| dc.date.accessioned | 2022-12-26T15:05:46Z | - |
| dc.date.available | 2022-12-26T15:05:46Z | - |
| dc.date.issued | 2019-02-01 | - |
| dc.identifier.issn | 1027-3719 | - |
| dc.identifier.issn | 1815-7920 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/9448 | - |
| dc.description.abstract | OBJECTIVE: To compare the prevalence of and trends in drug resistance in extra-pulmonary tuberculosis (EPTB) and pulmonary tuberculosis (PTB). METHODS: We retrospectively analysed the results of phenotypic drug susceptibility testing (DST) in culture-confirmed TB patients from January 2010 to December 2014 at seven university hospitals in South Korea. RESULTS: Of 5599 patients included, 320 (5.7%) were classified in the EPTB group and 5279 (94.3%) in the PTB group. The proportion of EPTB among all TB cases had gradually increased from 2010 to 2014 (P = 0.004). Among both new and previously treated patients, there were no significant differences in rates of resistance to any kind of anti-tuberculosis drug between the EPTB and PTB groups. The trends in drug resistance rates among new patients were similar in both the EPTB and PTB groups. The rates of multidrug-resistant TB among new patients gradually decreased in both groups (P = 0.031 and P = 0.001, respectively). CONCLUSION: The prevalence of and trends in drug resistance among new patients are not significantly different between patients with EPTB and those with PTB. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | International Union Against Tuberculosis And Lung Disease/Union Internationale Contre la Tuberculose et les Maladies Respiratories | - |
| dc.title | Drug resistance in extra-pulmonary tuberculosis in South Korea: comparison with pulmonary tuberculosis | - |
| dc.type | Article | - |
| dc.publisher.location | 프랑스 | - |
| dc.identifier.doi | 10.5588/ijtld.18.0109 | - |
| dc.identifier.scopusid | 2-s2.0-85065448606 | - |
| dc.identifier.wosid | 000459791400007 | - |
| dc.identifier.bibliographicCitation | International Journal of Tuberculosis and Lung Disease, v.23, no.2, pp 151 - + | - |
| dc.citation.title | International Journal of Tuberculosis and Lung Disease | - |
| dc.citation.volume | 23 | - |
| dc.citation.number | 2 | - |
| dc.citation.startPage | 151 | - |
| dc.citation.endPage | + | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Infectious Diseases | - |
| dc.relation.journalResearchArea | Respiratory System | - |
| dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
| dc.relation.journalWebOfScienceCategory | Respiratory System | - |
| dc.subject.keywordPlus | EXTRAPULMONARY TUBERCULOSIS | - |
| dc.subject.keywordPlus | CULTURE | - |
| dc.subject.keywordAuthor | EPTB | - |
| dc.subject.keywordAuthor | TB | - |
| dc.subject.keywordAuthor | pulmonary | - |
| dc.subject.keywordAuthor | resistance | - |
| dc.subject.keywordAuthor | South Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
